FI86203B - Method for production of 1-methyl-1,4-androstadiene-3,17- dione - Google Patents
Method for production of 1-methyl-1,4-androstadiene-3,17- dione Download PDFInfo
- Publication number
- FI86203B FI86203B FI864887A FI864887A FI86203B FI 86203 B FI86203 B FI 86203B FI 864887 A FI864887 A FI 864887A FI 864887 A FI864887 A FI 864887A FI 86203 B FI86203 B FI 86203B
- Authority
- FI
- Finland
- Prior art keywords
- dione
- methyl
- androstadiene
- atcc
- fermentation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/02—Dehydrogenating; Dehydroxylating
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
1 862031 86203
Menetelmä 1-metyyli-l, 4-androstadieeni-3,17-dionin valmistamiseksiProcess for the preparation of 1-methyl-1,4-androstadiene-3,17-dione
Keksintö koskee menetelmää 1-metyyli-l,4-androsta-5 dieeni-3,17-dionin valmistamiseksi, jolle menetelmälle on tunnusomaista, että fermentoidaan 17fi-hydroksi-l-metyyli-5a-androst-l-en-3-onia (metenolonia) sukuun Nocardia, Mycobacterium tai Fusarium kuuluvien mikro-organismien viljelmän kanssa, 10 Keksinnön mukainen menetelmä toteutetaan olosuh teissa, joita tavallisesti käytetään substraattien mikrobiologisessa dehydrauksessa mikro-organismiviljelmien avulla. Niinpä yleensä ensin määritetään tavanomaisissa esikokeissa analyyttisesti, erityisesti ohutkerroskromato-15 grafisesti, edullisimmat fermentointiolosuhteet, kuten esimerkiksi edullisimman ravintoalustan, soveltuvan substraatin liuotus- tai suspendointiaineen, substraattipitoi-suuden, teknisten olosuhteiden, kuten lämpötilan, ilmastuksen ja pH-arvon, ja kasvatuksen, substraatin lisäämisen 20 ja substraatin ja mikro-organismin entsyymin kontaktiin saattamisen parhaan ajan valinta.The invention relates to a process for the preparation of 1-methyl-1,4-androsta-5-diene-3,17-dione, which process is characterized by the fermentation of 17β-hydroxy-1-methyl-5α-androst-1-en-3-one ( methenolone) with a culture of microorganisms belonging to the genus Nocardia, Mycobacterium or Fusarium. The process according to the invention is carried out under conditions commonly used in the microbiological dehydration of substrates by cultures of microorganisms. Thus, in general, the most preferred fermentation conditions, such as the most preferred medium, a suitable substrate solvent or suspending agent, the substrate concentration, technical conditions such as temperature, aeration and pH, and the growth of the substrate, are generally determined analytically, in particular by thin layer chromatography, in conventional preliminary experiments. 20 and selection of the best time for contacting the substrate and the microorganism enzyme.
Tällöin on osoittautunut, että on tarkoituksenmukaista käyttää substraattipitoisuuksia noin 100 - 2000 mg/1 ravintoalustaa. pH säädetään edullisesti alueella 5 -'25 7 olevaan arvoon. Kasvatuslämpötila on alueella 20 - 40°C, edullisesti 25 - 35°C. Ilmastus tehdään edullisesti johtamalla 0,5 - 5 1 ilmaa minuutissa litraa kohden elatuslien-tä. Substraatin muuttumista on tarkoituksenmukaista seurata analysoimalla näyteuutteita.In this case, it has proved expedient to use substrate concentrations of about 100 to 2000 mg / l of culture medium. The pH is preferably adjusted to a value in the range of 5 to 25 7. The growth temperature is in the range of 20 to 40 ° C, preferably 25 to 35 ° C. The aeration is preferably carried out by passing 0.5 to 5 l of air per minute per liter of medium. It is appropriate to monitor substrate change by analyzing sample extracts.
30 Tähän fermentoitiin tarvittavat mikro-organismit ovat alan ammattimiesten vapaasti saatavissa tunnetuista mikro-organismikokoelmista. Soveltuvia kantoja ovat Nocar-diat, kuten Nocardia coralline ATCC 14350, mykobakteerit, kuten Mycobacterium rhodochrous ATCC 4276, tai Fusariumit, 35 kuten Fusarium solani ATCC 12823.The microorganisms required for this fermentation are freely available to those skilled in the art from known collections of microorganisms. Suitable strains include Nocardia such as Nocardia coralline ATCC 14350, mycobacteria such as Mycobacterium rhodochrous ATCC 4276, or Fusariums 35 such as Fusarium solani ATCC 12823.
2 862032 86203
Fermentoinnin jälkeen eristetään fermentointituot-teet sinänsä tunnetulla tavalla. Eristäminen voidaan tehdä esimerkiksi uuttamalla fermentointipanokset veteen sekoittamattomalla orgaanisella liuottimena, kuten etyyliase-5 taatilla, butyyliasetaatilla tai metyyli-isobutyyliketo- nilla, väkevöimällä uutteet ja puhdistamalla siten saadut raakatuotteet mahdollisesti kromatografisesti ja/tai kiteyttämällä.After fermentation, the fermentation products are isolated in a manner known per se. The isolation can be carried out, for example, by extracting the fermentation broths with a water-immiscible organic solvent such as ethyl acetate, butyl acetate or methyl isobutyl ketone, concentrating the extracts and purifying the crude products thus obtained, if necessary by chromatography and / or crystallization.
FI-hakemusjulkaisun 842 457 perusteella tiedetään, 10 että 1-metyyli-l,4-androstadieeni-3,17-dioni on farmakolo gisesti vaikuttava yhdiste, joka estää estraanibiosyntee-siä. Tekniikan tason mukaisesti yhdiste valmistetaan kemiallisesti 17B-hydroksi-1-metyyli-1,4-androstadien-3-onista, joka puolestaan valmistetaan hapettamalla mestero-15 Ionia Se02:lla (DE-patenttijulkaisu 1 174 778, Chem. Abstr. 61 (1964) 12059a). Menetelmän haittapuolena ovat huonot saannot, jotka ovat noin 15 % molemmat menetelmävaiheet mukaan lukien.It is known from FI application 842 457 that 1-methyl-1,4-androstadiene-3,17-dione is a pharmacologically active compound which inhibits estrane biosynthesis. According to the state of the art, the compound is chemically prepared from 17β-hydroxy-1-methyl-1,4-androstadien-3-one, which in turn is prepared by oxidation of the master-15 ion with SeO 2 (DE Patent 1,174,778, Chem. Abstr. 61 (1964)). ) 12059a). The disadvantage of the process is the poor yields of about 15% including both process steps.
Keksinnön mukaisella menetelmällä taas voidaan val-20 mistaa 1-metyyli-l,4-androstadieeni-3,17-dionia yksivaiheisen reaktion avulla saannon ollessa yli 60 %.By the process of the invention, on the other hand, 1-methyl-1,4-androstadiene-3,17-dione can be prepared by a single-step reaction in a yield of more than 60%.
Teoksen Microbial Transformations of Steroids, Academic Press 1967, sivulla 89 mainittujen julkaisujen perusteella on tunnettua, että analoginen yhdiste 1,4-and-25 rostadieeni-3,17-dioni voidaan valmistaa vain hyvin huonolla saannolla 4,5-asemassa tyydyttyneistä steroideista, ja jopa 4-androsteeni-3,17-dionin dehydratoinnissa muodostuu 1,4-androstadieeni-3,17-dionin vain hyvin epätyydyttävin saannoin.It is known from the publications cited in Microbial Transformations of Steroids, Academic Press 1967, page 89, that the analogous compound 1,4-and-25 rostadiene-3,17-dione can be prepared only in very poor yield from steroids saturated at the 4,5-position, and even in the dehydration of 4-androstene-3,17-dione, 1,4-androstadiene-3,17-dione is formed only in very unsatisfactory yields.
30 Seuraavat toteutusesimerkit valaisevat keksinnön mukaista menetelmää.The following embodiments illustrate the method according to the invention.
. . Esimerkki 1 2 l:n erlenmeyerpulloon, joka sisältää 500 ml autoklaavissa lämpötilassa 120°C 30 minuuttia steriloitua ra-: ·. 35 vintoliuosta, joka sisältää 0,5 % dekstroosimonohydraat- 3 8c203 tia, 0,5 % hiivauutetta, 0,2 % maissin liuotuslientä ja 0,1 % peptonia, pH 7,5, siirrostetaan Nocardia corallina ATCC 14350 -kannan agarvinopintaviljelmä, ja ravistellaan 48 tuntia pyöröravistimella lämpötilassa 30°C.. . Example 1 In a 2 l Erlenmeyer flask containing 500 ml of sterilized cereal in an autoclave at 120 ° C for 30 minutes. 35 vintages containing 0.5% dextrose monohydrate-3 8c203, 0.5% yeast extract, 0.2% corn broth and 0.1% peptone, pH 7.5 are inoculated into an agar surface culture of Nocardia Corallina strain ATCC 14350 and shaken 48 hours on a rotary shaker at 30 ° C.
5 250 ml em. esiviljelmää siirrostetaan 20 l:n esi- fermenttoriin, johon on laitettu 15 1 1,1 barin ylipaineessa 121°C:n lämpötilassa 30 minuuttia steriloitua ravintoalustaa, jolla on samanlainen koostumus kuin esivilje-lyyn käytetyllä. Silicon SH:ta lisätään vaahtoamisenesto-10 aineeksi ja seosta fermentoidaan 24 tuntia lämpötilassa 29°C ja 0,7 barin ylipaineessa ilmastaen (15 1/min) ja sekoittaen (220 kierrosta/min).5,250 ml of the above preculture are inoculated into a 20 l pre-fermentor in which 15 l of a medium having a composition similar to that used for the preculture has been sterilized for 30 minutes at an overpressure of 1.1 bar at 121 ° C. Silicon SH is added as antifoam and the mixture is fermented for 24 hours at 29 ° C and 0.7 bar overpressure with aeration (15 l / min) and stirring (220 rpm).
Sen jälkeen 0,9 1 esifermenttoriviljelmää poistetaan steriileissä olosuhteissa ja siirrostetaan 20 l:n 15 pääfermenttoriin, joka sisältää 14 1 steriloitua ravinto-liuosta, jolla on sama koostumus kuin esifermenttorivilje-lyyn käytetyllä. Viljelmää kasvatetaan 6 tuntia esifermen-tointiolosuhteissa, lisätään suodattamalla steriloitu liuos, joka sisältää 4,5 g metenolonia 60 ml:ssa diform-20 amidia, ja jatketaan sekoitusta ja ilmastusta.The 0.9 L pre-fermenter culture is then removed under sterile conditions and inoculated into a 20 L 15 main fermentor containing 14 L of sterilized nutrient solution having the same composition as that used for the pre-fermenter culture. The culture is grown for 6 hours under pre-fermentation conditions, a sterilized solution containing 4.5 g of methenolone in 60 ml of diform-20 amide is added by filtration, and stirring and aeration are continued.
56 tunnin kontaktiajän kuluttua reaktio on mennyt loppuun. Viljelmäliemi uutetaan kerran puolella ja sen jälkeen kahdesti kolmasosalla viljelmän tilavuudesta metyyli -isobutyyliketonia, uutteet väkevöidään ja haihdute-·' 25 taan kuiviin alipaineessa. Jäännös sekoitetaan vaahtoami- V senestoaineen poistamiseksi metanoliin, liukenematon vaahtoamisenestoaine erotetaan suodattamalla kaksinkertaisen poimusuodattimen läpi, liuos käsitellään aktiivihiilellä ja haihdutetaan uudelleen kuiviin. Jäännös uudel-30 leenkiteytetään sitten etyyliasetaatista ja kuivataan va- kuumiuunissa. Saadaan 2,42 g (54,6 % teoreettisesta saan-; nosta) 1-metyyliandrostadieenidionia, jonka sulamispiste on 164 - 166°C. 1-metyyliandrostadieenidionia saadaan lisää 0,45 g (10 % teoreettisesta saannosta) puhdistamalla ki-; 35 teytysemäliuos pylväskromatografisesti.After a contact time of 56 hours, the reaction is complete. The culture broth is extracted once with half and then twice with one third of the culture volume with methyl isobutyl ketone, the extracts are concentrated and evaporated to dryness under reduced pressure. The residue is stirred to remove the antifoam in methanol, the insoluble antifoam is separated by filtration through a double corrugated filter, the solution is treated with activated carbon and re-evaporated to dryness. The residue is then recrystallized from ethyl acetate and dried in a vacuum oven. 2.42 g (54.6% of theory) of 1-methylandrostadiene dione with a melting point of 164-166 ° C are obtained. An additional 0.45 g (10% of theory) of 1-methylandrostadiene dione is obtained by purification of 35 column chromatography.
4 862034 86203
Esimerkki 2Example 2
Esimerkin 1 mukaisissa olosuhteissa saatetaan mete-noloni reagoimaan 1-metyyliandrostadieenidioniksi käyttämällä Mycobacterium rhodochrous ATCC 4276 -kantaa.Under the conditions of Example 1, methenolone is reacted to 1-methylandrostadiene dione using Mycobacterium rhodochrous strain ATCC 4276.
5 Esimerkki 35 Example 3
Esimerkin 1 mukaisissa olosuhteissa, mutta käyttämällä ravintoalustaa, joka sisältää 3 % glukoosia, 1 % maissin liotuslientä 0,2 % NaN03, 0,1 % KH2P04, 0,2 % K2HP04 , 0,05 % MgS04 · 7H20, 0,002 % FeS04 · 7H20 ja 0,05 % 10 KC1, saatetaan metenoloni reagoimaan 1-metyyliandrostadi-eenidioniksi käyttämällä Fusarium solani ATCC 12823 -kantaa.Under the conditions of Example 1, but using a medium containing 3% glucose, 1% corn steep liquor 0.2% NaNO 3, 0.1% KH 2 PO 4, 0.2% K 2 HPO 4, 0.05% MgSO 4 · 7H 2 O, 0.002% FeSO 4 · 7H 2 O and 0.05% 10 KCl, reacting methenolone to 1-methylandrostadiene dione using Fusarium solani strain ATCC 12823.
Claims (2)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853512328 DE3512328A1 (en) | 1985-04-03 | 1985-04-03 | METHOD FOR PRODUCING 1-METHYL-1,4-ANDROSTADIEN-3,17-DION |
DE3512328 | 1985-04-03 | ||
DE8600130 | 1986-03-26 | ||
PCT/DE1986/000130 WO1986005813A1 (en) | 1985-04-03 | 1986-03-26 | Process for the production of 1-methyl-1,4-androstadien-3,17-dion |
Publications (4)
Publication Number | Publication Date |
---|---|
FI864887A FI864887A (en) | 1986-12-01 |
FI864887A0 FI864887A0 (en) | 1986-12-01 |
FI86203B true FI86203B (en) | 1992-04-15 |
FI86203C FI86203C (en) | 1992-07-27 |
Family
ID=6267294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI864887A FI86203C (en) | 1985-04-03 | 1986-12-01 | FRAME FOR THE FRAMSTATION OF AV 1-METHYL-1,4-ANDROSTADIENE-3,17-DION. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0217840B1 (en) |
JP (1) | JPH0665319B2 (en) |
CS (1) | CS271325B2 (en) |
DD (1) | DD244566A5 (en) |
DE (2) | DE3512328A1 (en) |
FI (1) | FI86203C (en) |
HU (1) | HU204575B (en) |
WO (1) | WO1986005813A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5873300A (en) * | 1999-07-07 | 2001-01-30 | Pharmacia & Upjohn Company | Process to prepare exemestane |
CA2474575A1 (en) * | 2002-02-01 | 2003-08-07 | Edward J. Herrington | Process for fermentation of phytosterols to androstadienedione |
GB2407227B (en) * | 2003-09-08 | 2006-11-08 | Deluxe Lab Inc | Program encoding and counterfeit tracking system and method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3322285A1 (en) * | 1983-06-18 | 1984-12-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | 1-ALKYL-ANDROSTA-1,4-DIEN-3,17-DIONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
-
1985
- 1985-04-03 DE DE19853512328 patent/DE3512328A1/en not_active Withdrawn
-
1986
- 1986-03-26 HU HU864337A patent/HU204575B/en not_active IP Right Cessation
- 1986-03-26 JP JP61501965A patent/JPH0665319B2/en not_active Expired - Lifetime
- 1986-03-26 EP EP86901819A patent/EP0217840B1/en not_active Expired
- 1986-03-26 DE DE8686901819T patent/DE3667491D1/en not_active Expired - Lifetime
- 1986-03-26 WO PCT/DE1986/000130 patent/WO1986005813A1/en active IP Right Grant
- 1986-04-01 DD DD86288631A patent/DD244566A5/en unknown
- 1986-04-03 CS CS862408A patent/CS271325B2/en unknown
- 1986-12-01 FI FI864887A patent/FI86203C/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0217840A1 (en) | 1987-04-15 |
HU204575B (en) | 1992-01-28 |
FI864887A (en) | 1986-12-01 |
JPH0665319B2 (en) | 1994-08-24 |
DE3667491D1 (en) | 1990-01-18 |
DE3512328A1 (en) | 1987-03-19 |
FI86203C (en) | 1992-07-27 |
FI864887A0 (en) | 1986-12-01 |
DD244566A5 (en) | 1987-04-08 |
WO1986005813A1 (en) | 1986-10-09 |
CS271325B2 (en) | 1990-09-12 |
EP0217840B1 (en) | 1989-12-13 |
CS240886A2 (en) | 1990-02-12 |
JPS62502935A (en) | 1987-11-26 |
HUT47645A (en) | 1989-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3112470A1 (en) | Method for producing antimicrobial agents | |
EP0322081B1 (en) | Microbiological preparation of 9-alpha-hydroxy-17-keto steroids | |
FI86203B (en) | Method for production of 1-methyl-1,4-androstadiene-3,17- dione | |
US5004695A (en) | Microbiological process for preparing 9α-hydroxy-4-androstene-3,17-dione | |
US4379842A (en) | Process for the manufacture of 1α-hydroxydehydroepiandrosterone | |
US5275936A (en) | Process for the preparation of 1-methyl-1,4-androstadiene-3,17-dione | |
RU2213777C2 (en) | Method for microbiological oxidation of 2-methyl- quinoxaline (variants) | |
EP0786011B1 (en) | Microbiological process for the preparation of 1-unsaturated 17-beta-carboxysubstituted 3-oxo-4-azaandrostan-3-ones | |
USRE29163E (en) | 1,2,3,4,10,19-Hexanor-9-oxo-5,9-seco-25D-spirostan-5-oic acid | |
US7300771B2 (en) | Process to produce 19-nor-10β-carboxylic acids by fungal oxidation of 6-substituted-Δ6-pregnanes | |
JPH0569512B2 (en) | ||
US3829447A (en) | (-)-9-oxo-5(s)-hydroxy decanoic acid lactone | |
US4220716A (en) | Process for the preparation of 7α-hydroxylated steroids | |
JP3754785B2 (en) | Method for producing 3-hydroxy nitrogen-containing six-membered ring compound | |
CA2338308A1 (en) | Microbial process for preparation of optically active 3-hydroxypyrrolidine derivatives | |
GB2103620A (en) | Microbial production of testosterone and 1-dehydrotestosterone | |
JPH0614875B2 (en) | Hydroxylation of 11β-position of steroids | |
JPH04248989A (en) | Production of 8-hydroxycarbostyril and/or 8-hydroxycoumarin | |
JPH0353315B2 (en) | ||
HU226215B1 (en) | Use of microorgamisms for o-demethylating | |
JPH0369894B2 (en) | ||
KR20020071633A (en) | A purification method of pravastatin precursor compactin and derivatives thereof using HP20 resin and isopropyl alcohol | |
MXPA99008015A (en) | Microbi biotransformation | |
EP0228414A1 (en) | Process for preparing 4-hydroxycyclopent-2-en-1-one | |
CZ2000512A3 (en) | Process of microbial oxidation of 2-methylquinoxaline to 2-quinoxaline carboxylic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: SCHERING AKTIENGESELLSCHAFT |